Dresden, Germany

Dirk Pamperin

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Apogepha Arzneimittel Gmbh. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dirk Pamperin. Retrieved from https://idiyas.com/inventor/dirk-pamperin-sc5sjmd8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dirk Pamperin

Introduction

Dirk Pamperin is a notable inventor based in Dresden, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms. His innovative work focuses on enhancing the delivery and effectiveness of active ingredients in medication.

Latest Patents

Dirk Pamperin holds a patent for an oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient. This patent describes the production of oral pharmaceutical compositions containing propiverine in amounts ranging from 4 mg to 60 mg. The compositions are designed to provide a prolonged release of the active agent, utilizing a blend of the active ingredient and one or more acidic substances with a pK value of less than 6.65. These formulations are either coated with a retarding layer or embedded in a matrix that may also be coated with additional retarding layers.

Career Highlights

Dirk Pamperin is associated with Apogepha Arzneimittel GmbH, where he applies his expertise in pharmaceutical innovations. His work has contributed to advancements in drug formulation and delivery systems, enhancing patient outcomes through improved medication efficacy.

Collaborations

Dirk has collaborated with notable colleagues such as Thomas Gramatte and Peter Gruber. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.

Conclusion

Dirk Pamperin's contributions to pharmaceutical innovations, particularly in oral dosage forms, highlight his commitment to improving medication delivery systems. His work continues to influence the industry and enhance patient care through effective drug formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…